Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1381861-91-1
1393330-41-0
1415800-38-2
1623792-00-6
782475-37-0
1807503-92-9
84048-28-2 | 7BETA-ACETOXY-1ALPHA,6BETA-DIHYDROXY-8,13-EPOXY-LABD-14-EN-11-ONE | AA00GCO2 | MFCD00133016
78385-84-9 | 4-Fluorobicyclo[2.2.2]octane-1-carboxylic acid | AA00GGYZ | MFCD20638766
84940-51-2 | Pyridine, 4-(difluoromethyl)-2-fluoro- (9CI) | AA00GKPG | MFCD19442245
79096-54-1 | 1-(3-Chloropropoxy)-4-nitrobenzene | AA00GN2I | MFCD00024686
78962-43-3 | 4,6-Di-O-benzylidene-1,2,3-tri-O-acetyl-β-D-galactopyranose | AA00GPVQ | MFCD09952855
932-49-0 | 1-(2-Hydroxyethyl)imidazolidine-2-thione | AA00GRDP | MFCD00022413
874-77-1 | 1-(4-Methylpiperazine)acetonitrile | AA00GRNH | MFCD03840696
887268-19-1 | 2-Bromo-n,n-dimethyl-4-fluoroaniline | AA00GRV0 | MFCD04116317
885518-50-3 | 6-Bromo-1h-indazol-4-amine | AA00GS3V | MFCD07368220
933752-32-0 | 1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid | AA00GSCV | MFCD09027511
